View of EFFICACY AND COST-EFFECTIVENESS, COMPARISON OF 7-DAYS VONOPRAZAN VERSUS 14-DAYS ESOMEPRAZOLE BASED TRIPLE THERAPIES FOR TREATING HELICOBACTER PYLORI INFECTION IN PAKISTANI POPULATION: A RANDOMIZED CLINICAL TRIAL

Return to Article Details EFFICACY AND COST-EFFECTIVENESS, COMPARISON OF 7-DAYS VONOPRAZAN VERSUS 14-DAYS ESOMEPRAZOLE BASED TRIPLE THERAPIES FOR TREATING HELICOBACTER PYLORI INFECTION IN PAKISTANI POPULATION: A RANDOMIZED CLINICAL TRIAL Download Download PDF